{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:44:13Z","timestamp":1793198653126,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["222102310709"],"award-info":[{"award-number":["222102310709"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cellsig.2025.111965","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:11:53Z","timestamp":1750965113000},"page":"111965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Circ_0084927 promotes progression of intrahepatic cholangiocarcinoma by sponging miR-4725-5p to activate the PDPK1\/AKT\/mTOR signaling pathway"],"prefix":"10.1016","volume":"134","author":[{"given":"Chenxi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2025.111965_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111965_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10272","key":"10.1016\/j.cellsig.2025.111965_bb0015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111965_bb0020","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-00922-2","article-title":"Colorectal liver metastasis: molecular mechanism and interventional therapy","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111965_bb0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111965_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305300","article-title":"Lipid nanoparticles optimized for targeting and release of nucleic acid","volume":"36","author":"Jia","year":"2023","journal-title":"Adv. Mater."},{"issue":"32","key":"10.1016\/j.cellsig.2025.111965_bb0040","article-title":"A novel Trojan horse Nanotherapy strategy targeting the cPKM-STMN1\/TGFB1 Axis for effective treatment of intrahepatic cholangiocarcinoma","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","article-title":"Circular RNA vaccine in disease prevention and treatment","volume":"8","author":"Niu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111965_bb0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.111965_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy","volume":"80","author":"Tewari","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2025.111965_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12935-020-01417-2","article-title":"circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene","volume":"20","author":"Qu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-022-01306-2","article-title":"CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2025.111965_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/OTT.S437536","article-title":"Crosstalk between circRNA and tumor microenvironment of hepatocellular carcinoma: mechanism, function and applications","volume":"17","author":"Xie","year":"2024","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13046-022-02494-z","article-title":"CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3zeta","volume":"41","author":"Hao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111965_bb0085","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41418-018-0220-6","article-title":"Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes","volume":"26","author":"Chen","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2025.111965_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","article-title":"CircRNA in cancer: fundamental mechanism and clinical potential","volume":"505","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12943-021-01397-5","article-title":"SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions","volume":"20","author":"Jiang","year":"2021","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111965_bb0100","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1158\/1535-7163.MCT-15-0281","article-title":"A novel inhibitor of AKT1-PDPK1 interaction efficiently suppresses the activity of AKT pathway and restricts tumor growth in vivo","volume":"14","author":"Maemets-Allas","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-018-0935-5","article-title":"Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1\/mTOR pathway","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-020-1145-5","article-title":"Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation","volume":"19","author":"Han","year":"2020","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111965_bb0115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/cr.2015.82","article-title":"Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111965_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204826","article-title":"Exosome release delays senescence by disposing of obsolete biomolecules","volume":"10","author":"Zou","year":"2023","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111965_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Ilyas","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111965_bb0135","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/hbsn.2016.09.07","article-title":"Ablative therapies for intrahepatic cholangiocarcinoma","volume":"6","author":"Shindoh","year":"2017","journal-title":"HepatoBiliary Surgery Nutr."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111965_bb0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2326-6066.CIR-23-0486","article-title":"Reprogramming the intrahepatic cholangiocarcinoma immune microenvironment by chemotherapy and CTLA-4 blockade enhances anti\u2013PD-1 therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111965_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-020-00774-4","article-title":"Targeted therapies in advanced gastric Cancer","volume":"21","author":"Patel","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111965_bb0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7995","key":"10.1016\/j.cellsig.2025.111965_bb0160","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","article-title":"Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides","volume":"625","author":"Huang","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","article-title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR","volume":"15","author":"Wang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-023-02974-y","article-title":"Exosome-derived circKIF20B suppresses gefitinib resistance and cell proliferation in non-small cell lung cancer","volume":"23","author":"Wei","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111965_bb0185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s13402-023-00776-y","article-title":"circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53","volume":"46","author":"Cheng","year":"2023","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.cellsig.2025.111965_bb0190","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2022.09.004","article-title":"Rational development of combination therapies for biliary tract cancers","volume":"78","author":"Harding","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02259-0","article-title":"Hsa_circ_0125356 promotes gemcitabine resistance by modulating WNT canonical and non-canonical pathways via miR-582-5p\/FGF9 axis in non-small cell lung cancer","volume":"24","author":"Du","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111965_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01396-6","article-title":"Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications","volume":"20","author":"Tang","year":"2021","journal-title":"Mol. Cancer"},{"issue":"36","key":"10.1016\/j.cellsig.2025.111965_bb0215","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/s41388-021-01960-w","article-title":"Hypoxic exosomal HIF-1\u03b1-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis","volume":"40","author":"Zeng","year":"2021","journal-title":"Oncogene"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:31:53Z","timestamp":1762317113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"alternative-id":["S0898656825003808"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111965","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circ_0084927 promotes progression of intrahepatic cholangiocarcinoma by sponging miR-4725-5p to activate the PDPK1\/AKT\/mTOR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111965"}}